Cincinnati startup files for IPO, quietly moves headquarters

Cincor logo resembling brain imaging on a purple background- clinical-stage biopharmaceutical company

A biopharmaceutical startup with Cincinnati roots is making plans to go public with an initial offering that could top $180 million, months after inking a nine-figure fundraise that stands as one of the region’s largest.

CinCor Pharma Inc., a clinical-stage biopharmaceutical company developing treatments for hypertension and other cardio-renal diseases, this week launched its IPO roadshow, per a release. The move follows a $143 million Series B raised by the company in October.

Click here to read the complete story.

Story excerpt provided by Cincy Inno.

Written by Liz Engel.

Originally published January 6, 2021.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: